期刊文献+

天疱疮患者调节性B细胞与致病性抗体的相关性研究 被引量:1

Relationship of regulatory B cells with pathogenic antibodies in pemphigus
原文传递
导出
摘要 目的探讨调节性B细胞(Breg)在天疱疮发病中的免疫介导机制。方法以CD19^+CD24^hiCD38^hi作为Breg标记,流式细胞仪检测48例天疱疮患者及20例健康人外周血中Breg占CD19^+B细胞的比例,观察不同严重程度患者的Breg比例变化趋势。采用ELISA法检测患者血清中特异性抗Dsg1、Dsg3抗体滴度、亚型,分析其与Breg比例的相关性。结果天疱疮患者外周血Breg占CDf19+B细胞的比例(11.54%±0.97%)与健康对照组(8.19%±0.85%)相比差异有统计学意义(P=0.04),且急性期轻度患者该比例(5.17%±2.14%)与中度患者(11.38%±5.30%,P=0.042)、重度患者(11.17%±5.31%,P=0.046)相比,差异均有统计学意义;Breg比例与抗Dsgl抗体亚型IgG4以及IgG4/IgG1的比值均呈正相关(r值分别为0.527,0.565,P值均〈0.01)。结论Breg主要和抗体产生以及疾病活动相关,但其具体的作用机制尚待研究。 Objective To explore the mechanisms underlying the mediating effect of regulatory B (Breg) cells in the pathogenesis of pemphigus. Methods Peripheral blood specimens were collected from 48 patients with pemphigus at different degrees of severity and 20 healthy controls. Flow cytometry was conducted to analyze the frequency of Breg (CDI9±CD24hiCD38hi) cells in peripheral CD19^+ B cells, enzyme linked immunosorbent assay (ELISA) to determine the titer and subtypes of anti-desmoglein (Dsg) 1 and 3 antibodies in sera from these subjects. The relationship of anti-Dsg 1 and 3 antibodies with the frequency of Breg cells was assessed by Spearman's rank correlation test. Results Significant differences were observed in the proportion of Breg ceils in CD19^+ B cells between patients with pemphigus and healthy controls (11.54% ± 0.97% vs. 8.19% ± 0.85%, P = 0.04), as well as between patients with acute mild pemphigus and those with moderate and severe pemphigus (5.17% ± 2.14% vs. 11.38% ± 5.30% and 11.17% ± 5.31%, P = 0.042, 0.046, respectively). The frequency of Breg cells was positively correlated with the absorbance value for anti-Dsgl antibodies of IgG4 subclass and IgG4/IgG1 ratio(r = 0.527, 0.565, respectively, both P 〈 0.01 ). Conclusions Breg cells are mainly associated with the production of antibodies in and disease severity of pemphigus, while the actual mechanism of action remains unknown.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2012年第11期771-773,共3页 Chinese Journal of Dermatology
基金 国家自然科学基金面上项目(81171499) 上海市科委科研计划项目(10JC1410600)
关键词 天疱疮 B淋巴细胞 抗体 Pemphigus B lymphocytes Antibodies
  • 相关文献

参考文献12

  • 1Blair PA, Norefia LY, Flores-Borja F, et al. CD19+CD24hiCD38hi B ceils exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity, 2010, 32( 1 ):129-140.
  • 2Murrell DF, Dick S, Ahmed AR, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol, 2008, 58(6): 1043-1046.
  • 3Pftitze M, Niedermeier A, Hertl M, et al. Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus. Eur J Dermatol, 2007, 17( 1 ): 4-11.
  • 4李秋菊,党二乐,呼蕾,吴岩,刘振锋,何争,晋亮,王刚.天疱疮和大疱性类天疱疮患者外周血滤泡辅助性T细胞水平的研究[J].中华皮肤科杂志,2012,45(3):155-157. 被引量:12
  • 5Katz SI, Parker D, Turk JL. B-cell suppression of delayed hyper- sensitivity reactions. Nature, 1974, 251 (5475): 550-551.
  • 6Neta R, Salvin SB. Specific suppression of delayed hypersensiti- vity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity. J Immunol, 1974, 113(6): 1716-1725.
  • 7Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunoi, 2006, 176(2): 705-710.
  • 8Yanaba K, Bouaziz JD, Haas KM, et al. A regulatory B cell subset with a unique CDldhiCD5+ phenotype controls T celldependent inflammatory responses. Immunity, 2008, 28(5 ): 639-650.
  • 9Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood, 2011, 117(2): 530-541.
  • 10Bouaziz J-D, Calbo S, Maho-Vaillant M, et al. IL-10 produced by activated human B cells regulates CD4 (+) T-cell activation in vitro. Eur J Immunol, 2010, 40( 10): 2686-2691.

二级参考文献25

  • 1Kárpáti S,Anmgai M,Prussick R,et al.Pemphigus vulgafis antigen,a desmoglein type of cadherin,is localized within keratinocyte desmosomes.J Cell Biol,1993,122(2):409-415.
  • 2Black M,Mignogna D,Scully C.Number Ⅱ pemphigus vulgaris.J Oral Dis,2005,11(3):119-130.
  • 3Amagai M,Koch PJ,Nishikawa T,et al.Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis,the site of blister formation in patients.J Invest Dermatol,1996,106(2):351-355.
  • 4López-Robles E,Avalos-Díaz E,Vega-Memije E,et al.TNFalpha and IL-6 are mediators in the blistering process of pemphigus.Int J Dermatol,2001,40(3):185-188.
  • 5Caproni M,Giomi B,Cardinali C,et al.Further support for a role for Th2-like cytokines in blister formation of pemphigus.Clin Immunol,2001,98(2):264-271.
  • 6D'Auria L,Bonifati C,Mussi A,et al.Cytokines in the sera of patients with pemphigus vulgaris:interleukin-6 and tumour nocrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity.Eur Cytokine Netw,1997,8(4):383-387.
  • 7Bhol KC,Rojas AI,Khan IU,et al.Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.Cytokine,2000,12(7):1076-1083.
  • 8Veldman CM,Gebhard KL,Uter W,et al.T cell recognition of desmoglein 3 peptides in patients with pomphigus vulgaris and healthy individuals.J Immunol,2004,172(6):3883-3892.
  • 9Liu Z,Li N,Diaz LA.Inhibition of pemphigus vulgaris by targeting of the CD40-CD154 co-stimulatory pathway:a step toward antigen-specific therapy? J Invest Dermatol,2006,126(1):11-13.
  • 10Yancey KB. The pathophysiology of autoimmune blistering diseases, J Clin Invest, 2005, 115(4): 825-828.

共引文献13

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部